T-cell large granular lymphocyte leukemia medical therapy: Difference between revisions
No edit summary |
|||
(One intermediate revision by one other user not shown) | |||
Line 9: | Line 9: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
[[Category:Hematology|T-cell large granular lymphocyte leukemia]] | |||
[[Category:Types of cancer|T-cell large granular lymphocyte leukemia]] |
Latest revision as of 16:43, 30 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
T-cell large granular lymphocyte leukemia Microchapters |
Differentiating T-cell large granular lymphocyte leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell large granular lymphocyte leukemia medical therapy On the Web |
American Roentgen Ray Society Images of T-cell large granular lymphocyte leukemia medical therapy |
FDA on T-cell large granular lymphocyte leukemia medical therapy |
CDC on T-cell large granular lymphocyte leukemia medical therapy |
T-cell large granular lymphocyte leukemia medical therapy in the news |
Blogs on T-cell large granular lymphocyte leukemia medical therapy |
Risk calculators and risk factors for T-cell large granular lymphocyte leukemia medical therapy |
Overview
Medical Therapy
Pharmacotherapy
Alemtuzumab has been investigated for use in treatment of refractory T-cell large granular lymphocytic leukemia.[1]
References
- ↑ Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH (2004). "Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia". Blood. 103 (5): 1969–71. doi:10.1182/blood-2003-11-3951. PMID 14976065. Unknown parameter
|month=
ignored (help)